Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy

Carmen W. Sullivan, Heather Leutwyler, Laura B. Dunn, Bruce A. Cooper, Steven M. Paul, Jon D. Levine, Marilyn Hammer, Yvette P. Conley, Christine A. Miaskowski

Research output: Contribution to journalArticle

Abstract

Context: Patients with breast cancer who undergo chemotherapy (CTX) experience between 10 and 32 concurrent symptoms. An evaluation of how these symptoms cluster together and how these symptom clusters change over time may provide insights into how to treat these multiple co-occurring symptoms. Objectives: The purposes of this study were to determine the occurrence rates and severity ratings for 38 common symptoms, evaluate for differences in the number and types of symptom clusters, and evaluate for changes over time in these symptom clusters (i.e., before CTX, the week after CTX, and two weeks after CTX). Methods: At each of the assessments, a modified version of the Memorial Symptom Assessment Scale was used to assess the occurrence and severity of the 38 symptoms. Exploratory factor analyses were used to extract the symptom clusters. Results: Although across the two symptom dimensions (i.e., occurrence and severity) and the three assessments, eight distinct symptom clusters were identified, only five were relatively stable across both dimensions and across time (i.e., psychological, hormonal, nutritional, gastrointestinal, and epithelial). Two of the additional clusters varied by time but not by symptom dimension (i.e., sickness behavior and weight change). The CTX neuropathy cluster was identified only at the assessment performed in the week after CTX. Conclusion: These findings provide insights into the most common symptom clusters in patients undergoing CTX for breast cancer. In addition, the most common symptoms within each cluster appear to be relatively stable across the two dimensions, as well as across time.

Original languageEnglish (US)
JournalJournal of Pain and Symptom Management
DOIs
StateAccepted/In press - 2017

Fingerprint

Breast Neoplasms
Drug Therapy
Illness Behavior
Symptom Assessment
Statistical Factor Analysis
Psychology
Weights and Measures

Keywords

  • Breast cancer
  • Chemotherapy
  • Symptom clusters
  • Symptom occurrence
  • Symptom severity
  • Symptoms

ASJC Scopus subject areas

  • Nursing(all)
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Sullivan, C. W., Leutwyler, H., Dunn, L. B., Cooper, B. A., Paul, S. M., Levine, J. D., ... Miaskowski, C. A. (Accepted/In press). Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy. Journal of Pain and Symptom Management. https://doi.org/10.1016/j.jpainsymman.2017.08.008

Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy. / Sullivan, Carmen W.; Leutwyler, Heather; Dunn, Laura B.; Cooper, Bruce A.; Paul, Steven M.; Levine, Jon D.; Hammer, Marilyn; Conley, Yvette P.; Miaskowski, Christine A.

In: Journal of Pain and Symptom Management, 2017.

Research output: Contribution to journalArticle

Sullivan, Carmen W. ; Leutwyler, Heather ; Dunn, Laura B. ; Cooper, Bruce A. ; Paul, Steven M. ; Levine, Jon D. ; Hammer, Marilyn ; Conley, Yvette P. ; Miaskowski, Christine A. / Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy. In: Journal of Pain and Symptom Management. 2017.
@article{9d175c82476a4d67bc10bbb9e0489e3e,
title = "Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy",
abstract = "Context: Patients with breast cancer who undergo chemotherapy (CTX) experience between 10 and 32 concurrent symptoms. An evaluation of how these symptoms cluster together and how these symptom clusters change over time may provide insights into how to treat these multiple co-occurring symptoms. Objectives: The purposes of this study were to determine the occurrence rates and severity ratings for 38 common symptoms, evaluate for differences in the number and types of symptom clusters, and evaluate for changes over time in these symptom clusters (i.e., before CTX, the week after CTX, and two weeks after CTX). Methods: At each of the assessments, a modified version of the Memorial Symptom Assessment Scale was used to assess the occurrence and severity of the 38 symptoms. Exploratory factor analyses were used to extract the symptom clusters. Results: Although across the two symptom dimensions (i.e., occurrence and severity) and the three assessments, eight distinct symptom clusters were identified, only five were relatively stable across both dimensions and across time (i.e., psychological, hormonal, nutritional, gastrointestinal, and epithelial). Two of the additional clusters varied by time but not by symptom dimension (i.e., sickness behavior and weight change). The CTX neuropathy cluster was identified only at the assessment performed in the week after CTX. Conclusion: These findings provide insights into the most common symptom clusters in patients undergoing CTX for breast cancer. In addition, the most common symptoms within each cluster appear to be relatively stable across the two dimensions, as well as across time.",
keywords = "Breast cancer, Chemotherapy, Symptom clusters, Symptom occurrence, Symptom severity, Symptoms",
author = "Sullivan, {Carmen W.} and Heather Leutwyler and Dunn, {Laura B.} and Cooper, {Bruce A.} and Paul, {Steven M.} and Levine, {Jon D.} and Marilyn Hammer and Conley, {Yvette P.} and Miaskowski, {Christine A.}",
year = "2017",
doi = "10.1016/j.jpainsymman.2017.08.008",
language = "English (US)",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy

AU - Sullivan, Carmen W.

AU - Leutwyler, Heather

AU - Dunn, Laura B.

AU - Cooper, Bruce A.

AU - Paul, Steven M.

AU - Levine, Jon D.

AU - Hammer, Marilyn

AU - Conley, Yvette P.

AU - Miaskowski, Christine A.

PY - 2017

Y1 - 2017

N2 - Context: Patients with breast cancer who undergo chemotherapy (CTX) experience between 10 and 32 concurrent symptoms. An evaluation of how these symptoms cluster together and how these symptom clusters change over time may provide insights into how to treat these multiple co-occurring symptoms. Objectives: The purposes of this study were to determine the occurrence rates and severity ratings for 38 common symptoms, evaluate for differences in the number and types of symptom clusters, and evaluate for changes over time in these symptom clusters (i.e., before CTX, the week after CTX, and two weeks after CTX). Methods: At each of the assessments, a modified version of the Memorial Symptom Assessment Scale was used to assess the occurrence and severity of the 38 symptoms. Exploratory factor analyses were used to extract the symptom clusters. Results: Although across the two symptom dimensions (i.e., occurrence and severity) and the three assessments, eight distinct symptom clusters were identified, only five were relatively stable across both dimensions and across time (i.e., psychological, hormonal, nutritional, gastrointestinal, and epithelial). Two of the additional clusters varied by time but not by symptom dimension (i.e., sickness behavior and weight change). The CTX neuropathy cluster was identified only at the assessment performed in the week after CTX. Conclusion: These findings provide insights into the most common symptom clusters in patients undergoing CTX for breast cancer. In addition, the most common symptoms within each cluster appear to be relatively stable across the two dimensions, as well as across time.

AB - Context: Patients with breast cancer who undergo chemotherapy (CTX) experience between 10 and 32 concurrent symptoms. An evaluation of how these symptoms cluster together and how these symptom clusters change over time may provide insights into how to treat these multiple co-occurring symptoms. Objectives: The purposes of this study were to determine the occurrence rates and severity ratings for 38 common symptoms, evaluate for differences in the number and types of symptom clusters, and evaluate for changes over time in these symptom clusters (i.e., before CTX, the week after CTX, and two weeks after CTX). Methods: At each of the assessments, a modified version of the Memorial Symptom Assessment Scale was used to assess the occurrence and severity of the 38 symptoms. Exploratory factor analyses were used to extract the symptom clusters. Results: Although across the two symptom dimensions (i.e., occurrence and severity) and the three assessments, eight distinct symptom clusters were identified, only five were relatively stable across both dimensions and across time (i.e., psychological, hormonal, nutritional, gastrointestinal, and epithelial). Two of the additional clusters varied by time but not by symptom dimension (i.e., sickness behavior and weight change). The CTX neuropathy cluster was identified only at the assessment performed in the week after CTX. Conclusion: These findings provide insights into the most common symptom clusters in patients undergoing CTX for breast cancer. In addition, the most common symptoms within each cluster appear to be relatively stable across the two dimensions, as well as across time.

KW - Breast cancer

KW - Chemotherapy

KW - Symptom clusters

KW - Symptom occurrence

KW - Symptom severity

KW - Symptoms

UR - http://www.scopus.com/inward/record.url?scp=85033359815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033359815&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2017.08.008

DO - 10.1016/j.jpainsymman.2017.08.008

M3 - Article

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

ER -